cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide

C20H26CoN4O2+ — CID 5255651

IUPACcobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide
SMILESCC(C[NH-])/N=C/c1ccccc1O.CC([NH-])C/N=C/c1ccccc1O.[Co+3]
InChIInChI=1S/2C10H13N2O.Co/c1-8(11)6-12-7-9-4-2-3-5-10(9)13;1-8(6-11)12-7-9-4-2-3-5-10(9)13;/h2*2-5,7-8,11,13H,6H2,1H3;/q2*-1;+3/b2*12-7+;
InChIKeyUWQRICUUDFDEIX-PZNGMHCYSA-N
MW413.39 g/mol
LogP4.50
Rot. Bonds6

About cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide

cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide (PubChem CID 5255651) has the molecular formula C20H26CoN4O2+ and a molecular weight of 413.39 g/mol. Its IUPAC name is cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide.

Molecular Properties

Compound Namecobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide
PubChem CID5255651
Molecular FormulaC20H26CoN4O2+
Molecular Weight413.39 g/mol
Exact Mass413.14
IUPAC Namecobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide
SMILESCC(C[NH-])/N=C/c1ccccc1O.CC([NH-])C/N=C/c1ccccc1O.[Co+3]
InChIInChI=1S/2C10H13N2O.Co/c1-8(11)6-12-7-9-4-2-3-5-10(9)13;1-8(6-11)12-7-9-4-2-3-5-10(9)13;/h2*2-5,7-8,11,13H,6H2,1H3;/q2*-1;+3/b2*12-7+;
InChIKeyUWQRICUUDFDEIX-PZNGMHCYSA-N
XLogP4.50
TPSA112.78 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500413.39
LogP ≤ 54.50
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide?
The IUPAC name of cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide (CID 5255651) is cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide.
What is the SMILES notation for cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide?
The canonical SMILES for cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide is CC(C[NH-])/N=C/c1ccccc1O.CC([NH-])C/N=C/c1ccccc1O.[Co+3].
What is the InChIKey of cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide?
The InChIKey is UWQRICUUDFDEIX-PZNGMHCYSA-N. The full InChI is InChI=1S/2C10H13N2O.Co/c1-8(11)6-12-7-9-4-2-3-5-10(9)13;1-8(6-11)12-7-9-4-2-3-5-10(9)13;/h2*2-5,7-8,11,13H,6H2,1H3;/q2*-1;+3/b2*12-7+;.
What are the key properties of cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide?
cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide has a molecular weight of 413.39 g/mol, XLogP of 4.50, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for cobalt(3+);1-[(2-hydroxyphenyl)methylideneamino]propan-2-ylazanide;2-[(2-hydroxyphenyl)methylideneamino]propylazanide is sourced from PubChem (CID 5255651), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).